Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.

Zekri AR, Salama H, Medhat E, Musa S, Abdel-Haleem H, Ahmed OS, Khedr HA, Lotfy MM, Zachariah KS, Bahnassy AA.

Stem Cell Res Ther. 2015 Jun 11;6:118. doi: 10.1186/s13287-015-0106-1.

2.

Differentially expressed genes in metastatic advanced Egyptian bladder cancer.

Zekri AR, Hassan ZK, Bahnassy AA, Khaled HM, El-Rouby MN, Haggag RM, Abu-Taleb FM.

Asian Pac J Cancer Prev. 2015;16(8):3543-9.

3.

Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.

Bahnassy AA, Zekri AR, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AA, El-Labbody SS.

World J Gastroenterol. 2014 Dec 28;20(48):18240-8. doi: 10.3748/wjg.v20.i48.18240.

4.

New insight into HCV E1/E2 region of genotype 4a.

Hussein N, Zekri AR, Abouelhoda M, Alam El-Din HM, Ghamry AA, Amer MA, Sherif GM, Bahnassy AA.

Virol J. 2014 Dec 30;11:231. doi: 10.1186/s12985-014-0231-y.

5.

IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.

Zekri AR, Salama H, Medhat E, Bahnassy AA, Morsy HM, Lotfy MM, Ahmed R, Darwish T, Marei MS.

Asian Pac J Cancer Prev. 2014;15(17):7213-8.

6.

Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.

Bahnassy AA, Fawzy M, El-Wakil M, Zekri AR, Abdel-Sayed A, Sheta M.

Transl Res. 2015 Mar;165(3):396-406. doi: 10.1016/j.trsl.2014.07.009. Epub 2014 Aug 7.

PMID:
25168019
7.

Promotor methylation: does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

N Zekri AR, Raafat AM, Elmasry S, Bahnassy AA, Saad Y, Dabaon HA, El-Kassas M, Shousha HI, Nassar AA, El-Dosouky MA, Hussein N.

Ann Hepatol. 2014 Sep-Oct;13(5):518-24.

8.

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease.

Salama H, Zekri AR, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA, Lotfy MM, Ahmed R, Musa S.

Stem Cell Res Ther. 2014 May 28;5(3):70. doi: 10.1186/scrt459.

9.

Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.

Zekri Ael-R, Nassar AA, El-Din El-Rouby MN, Shousha HI, Barakat AB, El-Desouky ED, Zayed NA, Ahmed OS, El-Din Youssef AS, Kaseb AO, Abd El-Aziz AO, Bahnassy AA.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6721-6.

10.

The independent effects of second hand smoke exposure and maternal body mass index on the anthropometric measurements of the newborn.

Wahabi HA, Mandil AA, Alzeidan RA, Bahnassy AA, Fayed AA.

BMC Public Health. 2013 Nov 9;13:1058. doi: 10.1186/1471-2458-13-1058.

11.

Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.

Bahnassy AA, Zekri AR, Salem SE, Abou-Bakr AA, Sakr MA, Abdel-Samiaa AG, Al-Bradei M.

Histol Histopathol. 2014 Feb;29(2):207-16. Epub 2013 Sep 2.

PMID:
23996743
12.

Gene expression profiling of non-hodgkin lymphomas.

Zekri AR, Hassan ZK, Bahnassy AA, Eldahshan DH, El-Rouby MN, Kamel MM, Hafez MM.

Asian Pac J Cancer Prev. 2013;14(7):4393-8.

13.

Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.

Högfeldt T, Johnsson P, Grandér D, Bahnassy AA, Porwit A, Eid S, Österborg A, Zekri AR, Lundahl J, Khaled MH, Mellstedt H, Moshfegh A.

Leuk Lymphoma. 2014 May;55(5):1158-65. doi: 10.3109/10428194.2013.824077. Epub 2013 Aug 31.

PMID:
23841503
14.

Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon.

Zekri AR, Bahnassy AA, Mohamed WS, Alam El-Din HM, Shousha HI, Zayed N, Eldahshan DH, Abdel-Aziz AO.

Virol J. 2013 Jul 1;10:218. doi: 10.1186/1743-422X-10-218.

15.

Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.

Zekri AR, Hassan ZK, Bahnassy AA, Sherif GM, ELdahshan D, Abouelhoda M, Ali A, Hafez MM.

Asian Pac J Cancer Prev. 2012;13(11):5433-8.

16.

Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures.

Högfeldt T, Bahnassy AA, Kwiecinska A, Osterborg A, Tamm KP, Porwit A, Zekri AR, Lundahl J, Khaled HM, Mellstedt H, Moshfegh A.

Leuk Lymphoma. 2013 May;54(5):996-1003. doi: 10.3109/10428194.2012.738365. Epub 2012 Nov 8.

PMID:
23046110
17.

Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women.

Zekri AR, Bahnassy AA, Mohamed WS, El-Kassem FA, El-Khalidi SJ, Hafez MM, Hassan ZK.

J Egypt Natl Canc Inst. 2012 Sep;24(3):123-31. doi: 10.1016/j.jnci.2012.06.001. Epub 2012 Jul 10.

18.

The major medical ethical challenges facing the public and healthcare providers in Saudi Arabia.

Alkabba AF, Hussein GM, Albar AA, Bahnassy AA, Qadi M.

J Family Community Med. 2012 Jan;19(1):1-6. doi: 10.4103/2230-8229.94003.

19.

Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.

Bahnassy AA, Zekri AR, Abou-Bakr AA, El-Deftar MM, El-Bastawisy A, Sakr MA, El-Sherif GM, Gaafar RM.

Exp Mol Pathol. 2012 Aug;93(1):154-61. doi: 10.1016/j.yexmp.2012.04.001. Epub 2012 Apr 6.

PMID:
22504106
20.

A case of synchronous double primary breast carcinoma and osteosarcoma: Mismatch repair genes mutations as a possible cause for multiple early onset malignant tumors.

Ahmed H, Salama A, Salem SE, Bahnassy AA.

Am J Case Rep. 2012;13:218-23. doi: 10.12659/AJCR.883382. Epub 2012 Sep 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk